Search:
Filter:
Sort:
The Jha brothers admitted selling counterfeit Keytruda and other prescription drugs to undercover agents.
Read More
PSM is soliciting feedback on draft best practices until June 20th. Please review the guidelines and send your thoughts to editors@safemedicines.org.
Read More
United States District Court Western District of Washington USA v Rajnish Kumar Jha Plea Agreement Filed June 2025 Read the document.
Read More
United States District Court Western District of Washington USA v Avanish Kumar Jha Plea Agreement Filed June 2025 Read the document.
Read More
Prescription Drug Affordability Board Activity, May 2025 Activities Summary Colorado: Colorado’s PDAB met on May 23 to approve the Data Submission Guide and begin rulemaking around an upper payment limit for Enbrel. Oregon: At its May 21 meeting Oregon’s PDAB discussed the timeline and process for affordability reviews and approved the generic drug report. One board member proposed looking beyond…
Read More
The FDA warned companies over the sale of an unapproved medical device and contaminated eye medicines, and disbarred a Texan who sold illegally imported pharmaceuticals.
Read More
The FDA has announced a voluntary nationwide recall of two dietary supplements sold exclusively online by www.umary-usa.com. Lab testing revealed that Unavy Ácido HIALURÓNICO and Umovy Ácido HIALURÓNICO contain undeclared active pharmaceutical ingredients: diclofenac, dexamethasone, and omeprazole.
Read More
Federally-registered compounding facilities stopped making tirzepatide on May 22. This transition is significant for patients, and we at PSM think there are four things you should be watching for.
Read More
Operation RapTor led to 270 arrests and the seizure of more than $200 million in currency and digital assets.
Read More
Articles in Endpoints News and the Houston Chronicle raise questions about the regulatory process for 503B compounding facilities.
Read More